NDC 68180-423

CEFIXIME

Cefixime

CEFIXIME is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Lupin Pharmaceuticals, Inc.. The primary component is Cefixime.

Product ID68180-423_88f79e17-9a30-4025-9fdc-d1311d78e895
NDC68180-423
Product TypeHuman Prescription Drug
Proprietary NameCEFIXIME
Generic NameCefixime
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2020-10-14
Marketing CategoryNDA AUTHORIZED GENERIC / NDA AUTHORIZED GENERIC
Application NumberNDA203195
Labeler NameLupin Pharmaceuticals, Inc.
Substance NameCEFIXIME
Active Ingredient Strength400 mg/1
Pharm ClassesCephalosporin Antibacterial [EPC],Cephalosporins [CS]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 68180-423-08

50 CAPSULE in 1 BOTTLE (68180-423-08)
Marketing Start Date2020-10-14
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "CEFIXIME" or generic name "Cefixime"

NDCBrand NameGeneric Name
16714-766Cefiximecefixime
16714-767Cefiximecefixime
43598-673CefiximeCefixime
43598-674CefiximeCefixime
62250-663Cefiximecefixime
62250-664Cefiximecefixime
67877-584CEFIXIMECEFIXIME
68180-416CEFIXIMECEFIXIME
68180-405CEFIXIMECEFIXIME
68180-407CEFIXIMECEFIXIME
62250-668CefiximeCefixime
65862-751CefiximeCefixime
65862-752CefiximeCefixime
68180-423CEFIXIMECEFIXIME
70518-2749CEFIXIMECEFIXIME
27437-201SUPRAXcefixime
27437-203SUPRAXcefixime
27437-205SUPRAXcefixime
27437-206SUPRAXcefixime
27437-207SUPRAXcefixime
27437-208SUPRAXcefixime
43063-537SUPRAXcefixime
54348-797SUPRAXCEFIXIME

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.